相关实验视频

Updated: Aug 11, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

限制的高通量查兼容性的phenuivirus上限绑定域

Janna Scherf¹, Dominik Vogel¹, Sheraz Gul^2,3

¹Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

Scientific reports

|December 22, 2023

概括

布尼亚病毒,就像裂谷热病病毒一样,在很少治疗的情况下,会给健康带来重大风险. 准它们的cap-snatching机制至关重要,但cap-binding域对药物发现的潜力有限.

科学领域:

病毒学病毒学
药物发现药物发现药物发现
分子生物学分子生物学

背景情况:

布尼亚病毒,包括裂谷热病毒,是重要的新兴病原体,具有有限的医学对策.
帽子抓取机制对于布尼亚病毒复制至关重要,涉及帽子结合和内核酶活动.
这些活动是可用药物的目标,就像在流感病毒中看到的那样.

研究的目的:

为了评估phenuivirus cap-binding域 (CBD) 作为抗病毒策略的药物标.
评估CBD对中高通量药物发现的适用性.

主要方法:

开发体外测试以检测CBD与m7GTP之间的相互作用.
关于CBD的结合口袋的特征和对帽子类型的亲和力.

主要成果:

现病毒CBD有一个浅的结合口袋.
而CBD对其天然的cap-ligand,m7GTP.有较低的亲和力.
这些特性限制了CBD作为小分子药物的点的潜力.

结论:

通过经典的体外 (in vitro) 方法对小分子药物向的潜力有限.
可能需要进行进一步的研究,以探索帽子抓取机器内的替代策略或目标.

更多相关视频

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

相关概念视频

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...